Evidence map›Paper›PMID 37750945›Full record

ArticleThe British journal of radiology2023

Imaging prediction of

Kuo-Chen Wu, Shang-Wen Chen, Te-Chun Hsieh, Kuo-Yang Yen, Chao-Jen Chang, Yu-Chieh Kuo, Yu-Ju Hsu, Ruey-Feng Chang, Chia-Hung Kao

Abstract read
In one paragraph

Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kuo-Chen WuGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
Shang-Wen ChenArtificial Intelligence Center, China Medical University Hospital, Taichung, Taiwan.
Te-Chun HsiehDepartment of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.
Kuo-Yang YenDepartment of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.
Chao-Jen ChangArtificial Intelligence Center, China Medical University Hospital, Taichung, Taiwan.
Yu-Chieh KuoArtificial Intelligence Center, China Medical University Hospital, Taichung, Taiwan.
Yu-Ju HsuArtificial Intelligence Center, China Medical University Hospital, Taichung, Taiwan.
Ruey-Feng ChangGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
Chia-Hung KaoArtificial Intelligence Center, China Medical University Hospital, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo predict KRAS mutation in rectal cancer (RC) through computer vision of [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) by using metric learning (ML).

methodsThis study included 160 patients with RC who had undergone preoperative PET/CT. KRAS mutation was identified through polymerase chain reaction analysis. This model combined ML with the deep-learning framework to analyze PET data with or without CT images. The Batch Balance Wrapper framework and K-fold cross-validation were employed during the learning process. A receiver operating characteristic (ROC) curve analysis was performed to assess the model's predictive performance.

resultsGenetic alterations in KRAS were identified in 82 (51%) tumors. Both PET and CT images were used, and the proposed model had an area under the ROC curve of 0.836 for its ability to predict a mutation status. The sensitivity, specificity, and accuracy were 75.3%, 79.3%, and 77.5%, respectively. When PET images alone were used, the area under the curve was 0.817, whereas the sensitivity, specificity, and accuracy were 73.2%, 79.6%, and 76.2%, respectively.

conclusionsThe ML model presented herein revealed that baseline 18F-FDG PET/CT images could provide supplemental information to determine KRAS mutation in RC. Additional studies are required to maximize the predictive accuracy. ADVANCES IN KNOWLEDGE: The results of the ML model presented herein indicate that baseline 18F-FDG PET/CT images could provide supplemental information for determining

Indexed as

Positron Emission Tomography Computed TomographyRectal NeoplasmsFluorodeoxyglucose F18HumansMutationPositron-Emission TomographyProto-Oncogene Proteins p21(ras)RadiopharmaceuticalsFluorodeoxyglucose F18KRAS protein, humanProto-Oncogene Proteins p21(ras)Radiopharmaceuticals

Identifiers

PMID37750945
PMCPMC10607399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.